Tuberculosis (TB) is a leading cause of death in patients infected with Human Immunodeficiency Virus (HIV), and HIV infection is the most potent risk factor for the development of active TB disease from a latent TB infection. This study aims to determine the seroprevalence of HIV among newly diagnosed TB patients in Kassala state eastern Sudan. This was a descriptive, hospital-based, cross-sectional study of 251 active and newly diagnosed TB patients, selected by simple random sampling. Blood samples and demographic data were collected from each patient. TB was diagnosed by direct ZN smear and molecular detection by Xpert MTB/RIF. The serum samples were tested for HIV using 4th generation enzyme-linked immunosorbent assay (ELISA). The prevalence of HIV was 13.9% (35/251), the infection rate among pulmonary TB was 17%, whereas that in extrapulmonary TB was 4.8%, the prevalence was (18.2%) in the males, and (7.2%) in the females. In conclusion: TB/HIV co-infection in the Eastern part of Sudan was high compared with the global prevalence, all TB patients should therefore be assessed for HIV risk factors and advised to undergo HIV testing.

Objective: This study aimed to assess the level of awareness about Hepatitis B infection, and the HBV testing and vaccination history among students of medical laboratory sciences (MLS) at Sudan international university.Results: A total of 271 students responded to the questionnaire. Among them, 67% were females, and 33% were males with a mean age of 20.93 ± 1.6 years. Only 66 (24.4%) students were vaccinated against hepatitis B, whereas 205 (75.6%) students had never been vaccinated. Out of all study participants, 121 (44.6%) had never been tested for HBV. Among the study participants, 60.4% had good knowledge about HBV, 85% had a positive attitude toward HBV, and 85% had good practices related to HBV. The mean awareness score was 18.3, with 64% of participants having satisfactory awareness about HBV. Moreover, this awareness was significantly predicted by the study level of the student (P = .000). Being on the fourth year of study was associated with satisfactory awareness about HBV (OR = 0.41, 95% CI 0.188–0.889).

Background: Parvovirus B19 is a human pathogenic virus associated with a wide range of clinical conditions. During pregnancy congenital infection with parvovirus B19 can be associated with poor outcome, including miscarriage, fetal anemia and non-immune hydrops. Objective: The study aimed to determine the prevalenceof Parvovirus B19 DNA in pregnant women attending the Military hospital in Khartoum, demonstrating the association between the virus and poor pregnancy outcomes. Materials and methods: This study was a cross sectional study, testing pregnant Sudanese women whole blood samples (n= 97) for the presence of Parvovirus B19 DNA using nested PCR technique. Result: Two samples were found positive for Parvovirus B19 DNA out of the total number of samples screened. Conclusions: The prevalence of Parvovirus B19 DNA among pregnant women attending the Military hospital was 2.1%.

No abstract

Background: Parvovirus B19 is a human pathogenic virus associated with a wide range of clinical conditions. During pregnancy congenital infection with parvovirus B19 can be associated with poor outcome, including miscarriage, fetal anemia and non-immune hydrops.   Objective: The study aimed to determine the prevalenceof Parvovirus B19 DNA in pregnant women attending the Military hospital in Khartoum, demonstrating the association between the virus and poor pregnancy outcomes. Subjects and methods: This study was a cross sectional study, testing pregnant Sudanese women whole blood samples (n= 97) for the presence of Parvovirus B19 DNA using nested PCR technique. Result: Two samples were found positive for Parvovirus B19 DNA out of the total number of samples screened. Conclusions: The prevalence of Parvovirus B19 DNA among pregnant women attending the Military hospital was 2.1%.